Breast Cancer Research and Treatment

, Volume 81, Issue 3, pp 243–251 | Cite as

Breast Cancer in Elderly Women: is Partial Breast Irradiation a Good Alternative?

  • J.M. Hannoun-Levi
  • A. Courdi
  • H. Marsiglia
  • M. Namer
  • J.P. Gerard


Background. Approximately half of all breast cancer occurs after age 65. Several aspects for the treatment of early breast cancer may be influenced by patient age, including postoperative radiation therapy (RT), in order to prevent the risk of local recurrence (LR). Postoperative adjuvant RT, improving the chances of local control, is not always completed because of comorbidity-associated factors. Does an alternative exist between a 5-week radiotherapy regime and no irradiation after breast conservative surgery without burdening the overall therapeutic management?

Methods. The authors review the literature regarding age-specific issues in the irradiation of breast cancer and the potential role of a partial breast irradiation (PBI) to prevent LR in the ipsilateral breast.

Results. Phase II and III trials have been analyzed for feasibility, efficacy and toxicity. PBI may be delivered with low or high dose rate brachytherapy and intra operative, or external beam radiation therapy. PBI satisfies the control quality criteria. The majority of the teams provide PBI recurrence rates lower than 5% (0–4.4%) with a median follow-up varying between 8 and 72 months, associated with cosmetic results comparable to those achieved with conventional external beam.

Conclusions. Breast cancer in elderly women represents a medical and economical problem. The recommended conservative treatment includes RT for 50 Gy over 5 weeks. Some subgroups of patients did not receive radiotherapy because of comorbidity-associated factors or more favorable tumor biology. PBI seems to be an acceptable alternative to adjuvant RT over 5 weeks and no irradiation. The evaluation of toxicity and efficacy, especially in terms of local control, is necessary and large multicentric phase III trials comparing the two irradiation approaches are needed, including quality of life, economic considerations and longer follow-up.

breast cancer elderly partial irradiation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    GLOBOCAN 2000: Cancer Incidence, Mortality and PrevalenceWorldwide, Version 1.0. IARC CancerBase No. 5. Lyon, IARCPress, 2001Google Scholar
  2. 2.
    De Vathaire F, Koscielny S, Rezvani A: Réseau FRANCIM. Statistiques de santé. Estimation de l'incidence des cancers en France 1983-1987. Les éditions INSERM, Paris, 1996Google Scholar
  3. 3.
    Dinh Quang Chi: La population de la France à l'horizon 2050. Économie et Statistique, INSEE 274: 7–32, 1994Google Scholar
  4. 4.
    Balducci L, Lyman GH: Cancer in the elderly. Epidemiologic and clinical implications. Clin Geriatr Med 13: 1–14, 1997Google Scholar
  5. 5.
    Evans JG: Oxford Textbook of Geriatric Medicine. Introduction. 2nd edn, Oxford University Press, Oxford, 2000, pp 1–4Google Scholar
  6. 6.
    Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461, 1995Google Scholar
  7. 7.
    Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88: 1659–1664, 1996Google Scholar
  8. 8.
    Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348: 708–713, 1996Google Scholar
  9. 9.
    Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, Adami HO: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17: 2326–2333, 1999Google Scholar
  10. 10.
    Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R: Radiotherapy after breast-conserving surgery in small breast carcinoma: longterm results of a randomized trial. Ann Oncol 12: 997–1003, 2001Google Scholar
  11. 11.
    [No authors listed] Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355: 1757–1770, 2000Google Scholar
  12. 12.
    Robertson JF, Ellis IO, Elston CW, Blamey RW: Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. Eur J Cancer 28A: 908–910, 1992Google Scholar
  13. 13.
    Gazet JC, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, Lowndes S: Prospective randomized trial of tamoxifen v.s. surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207–214, 1994Google Scholar
  14. 14.
    Kantorowitz DA, Poulter CA, Sischy B, Paterson E, Sobel SH, Rubin P, Dvoretsky PA, Mishalak W, Doane KL: Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 15: 263–270, 1988Google Scholar
  15. 15.
    Reed MW, Morrison JM: Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast. Br J Surg 76: 898–900, 1989Google Scholar
  16. 16.
    Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67: 2079–2082, 1991Google Scholar
  17. 17.
    Bates T, Riley DL, Houghton J, Fallowfield L, Baum M: Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg 78: 591–594, 1991Google Scholar
  18. 18.
    von Rueden DG, Sessions SC: Alternative therapy for elderly patients with breast cancer. Am Surg 60: 72–78, 1994Google Scholar
  19. 19.
    Cooke AL, Perera F, Fisher B, Opeitum A, Yu N: Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. Int J Radiat Oncol Biol Phys 31: 777–781, 1995Google Scholar
  20. 20.
    de Csepel J, Tartter PI, Gajdos C: When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol 74: 273–277, 2000Google Scholar
  21. 21.
    Vlastos G, Mirza NQ, Meric F, Hunt KK, Kuerer HM, Ames FC, Ross MI, Buchholz TA, Hortobagyi GN, Singletary SE: Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 92: 1092–1100, 2001Google Scholar
  22. 22.
    Solin LJ, Schultz DJ, Fowble BL: Ten-year results of the treatment of early-stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 33: 45–51, 1995Google Scholar
  23. 23.
    Fowble B: An assessment of treatment options for breast conservation in the elderly woman with early stage breast cancer. Int J Radiat Oncol Biol Phys 31: 1015–1017, 1995Google Scholar
  24. 24.
    Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M: European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387, 2001Google Scholar
  25. 25.
    Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88: 716–726, 1996Google Scholar
  26. 26.
    Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85: 1104–1113, 1999Google Scholar
  27. 27.
    Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R: Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 89: 561–573, 2000Google Scholar
  28. 28.
    Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA: Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93: 1344–1346, 2001Google Scholar
  29. 29.
    Gruenberger T, Gorlitzer M, Soliman T, Rudas M, Mittlboeck M, Gnant M, Reiner A, Teleky B, Seitz W, Jakesz R: It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat 50: 37–46, 1998Google Scholar
  30. 30.
    Benhaim DI, Lopchinsky R, Tartter PI: Lumpectomy with tamoxifen as primary treatment for elderly women with earlystage breast cancer. Am J Surg 180: 162–166, 2000Google Scholar
  31. 31.
    Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550–556, 2000Google Scholar
  32. 32.
    Hughes KS, Schnaper L, Berry D, Wood C, Henderson C, Norton L: Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma. Proc Am Soc Clin Oncol 20: 24a (abstract 93), 2001Google Scholar
  33. 33.
    Fyles A, McCready D, Manchul L, Trudeau M, Olivotto I, Merante P, Pintilie M, Weir L: Preliminary results of a randomized study of tamoxifen +/-breast irradiation in T1/2 N0 disease in women over 50 years of age. Proc Am Soc Clin Oncol 20: 24a (abstract 92), 2001Google Scholar
  34. 34.
    Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20: 4141–4149, 2002Google Scholar
  35. 35.
    Silliman RA, Balducci L, Goodwin JS, Holmes FF, Leventhal EA: Breast cancer care in old age: what we know, don't know, and do. J Natl Cancer Inst 85: 190–199, 1993Google Scholar
  36. 36.
    Balducci L, Extermann M, Carreca I: Management of breast cancer in the older woman. Cancer Control 8: 431–434, 2001Google Scholar
  37. 37.
    Jewell WR, Krishnan L, Reddy EK, Thomas JH, Mansfield CM: Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast. Arch Surg 122: 687–690, 1987Google Scholar
  38. 38.
    Cionini L, Pacini P, Marzano S, Distante V, Cardona G, Bianchi S: Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon Chir 89: 128 (abstract 14), 1993Google Scholar
  39. 39.
    Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HM, Turner P, Chaudary MA, Rubens RD: Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 27: 447–450, 1991Google Scholar
  40. 40.
    Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, Turner P, Chaudary MA, Rubens RD: Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A: 608–611, 1996Google Scholar
  41. 41.
    Vicini F, Kini VR, Chen P, Horwitz E, Gustafson G, Benitez P, Edmundson G, Goldstein N, McCarthy K, Martinez A: Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 70: 33–40, 1999Google Scholar
  42. 42.
    Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, Edmundson G, Goldstein NS, Benitez P, Huang RR, Martinez A: Accelerated treatment of breast cancer. J Clin Oncol 19: 1993–2001, 2001Google Scholar
  43. 43.
    Kuske RR, Bolton JS, Wilenzick RM, McKinnon WMP, Pullen B, Scroggins TG, Zakris EL, Fineberg BB: Brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer. Int J Radiat Oncol Biol Phys 30: 245 (abstract 1004), 1994Google Scholar
  44. 44.
    King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180: 299–304, 2000Google Scholar
  45. 45.
    Krishnan L, Jewell WR, Tawfik OW, Krishnan EC: Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7: 91–96, 2001Google Scholar
  46. 46.
    Perera F, Engel J, Holliday R, Scott L, Girotti M, Girvan D, Chisela F, Venkatesan V: Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 65: 263–267, 1997Google Scholar
  47. 47.
    Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, Cady B, Ulin K, Ruthazer R, DiPetrillo TA: Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53: 889–897, 2002Google Scholar
  48. 48.
    Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, Mangel LC, Somogyi A, Kasler M, Nemeth G: Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80: 121–128, 2002Google Scholar
  49. 49.
    Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS: The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5: 278–283, 1993Google Scholar
  50. 50.
    Formenti SC, Rosenstein B, Skinner KA, Jozsef G: T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology 222: 171–178, 2002Google Scholar
  51. 51.
    Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, Ivaldi G, Tosi G, Ciocca M, Tosoni A, De Lucia F: A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37: 2178–2183, 2001Google Scholar
  52. 52.
    Dubois JB, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H: IORT in breast carcinomas. Front Radiat Ther Oncol 31: 131–137, 1997Google Scholar
  53. 53.
    Vaidya JS, Baum M, Tobias JS, D'Souza DP, Naidu SV, Morgan S, Metaxas M, Harte KJ, Sliski AP, Thomson E: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12: 1075–1080, 2001Google Scholar
  54. 54.
    Nag S: The evolving role of brachytherapy in breast cancer. Am J Clin Oncol 18: 353–357, 1995Google Scholar
  55. 55.
    White JR, Wilson JF: Brachytherapy and breast cancer. Semin Surg Oncol 13: 190–195, 1997Google Scholar
  56. 56.
    Buchholz TA, Austin-Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, Griffin TW: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26: 23–35, 1993Google Scholar
  57. 57.
    Leonard CE, Wood ME, Zhen B, Rankin J, Waitz DA, Norton L, Howell K, Sedlacek S: Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol 13: 2906–2615, 1995Google Scholar
  58. 58.
    Hebert-Croteau N, Freeman CR, Latreille J, Brisson J: Delay in adjuvant radiation treatment and outcomes of breast cancer-a review. Breast Cancer Res Treat 74: 77–94, 2002Google Scholar
  59. 59.
    Wazer DE, Lowther D, Boyle T, Ulin K, Neuschatz A, Ruthazer R, DiPetrillo TA: Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50: 107–111, 2001Google Scholar
  60. 60.
    Boyages J, Bilous M, Barraclough B, Langlands AO: Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother Oncol 13: 69–74, 1988Google Scholar
  61. 61.
    Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA: Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52: 1132–1139, 2002Google Scholar
  62. 62.
    Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, Arthur D, Scroggins T, Streeter O: Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breastconserving therapy. Int J Radiat Oncol Biol Phys 55: 289–293, 2003Google Scholar
  63. 63.
    Dutreix J, Cosset JM, Girinsky T: Biological equivalency of high single doses used in intraoperative irradiation. Bull Cancer Radiother 77: 125–134, 1990Google Scholar
  64. 64.
    Kimmick GG, Balducci L: Breast cancer and aging. Clinical interactions. Hematol Oncol Clin North Am 14: 213–234, 2000Google Scholar
  65. 65.
    Yancik R, Ries LA: Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14: 17–23, 2000Google Scholar
  66. 66.
    Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF: ‘Residual’ mammary carcinoma following simulated partial mastectomy. Cancer 35: 739–747, 1975Google Scholar
  67. 67.
    Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, Schnitt SJ, Silver B, Boyages J, Harris JR: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8: 113–118, 1990Google Scholar
  68. 68.
    Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57: 1717–1724, 1986Google Scholar
  69. 69.
    Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL: Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19: 833–842, 1990Google Scholar
  70. 70.
    Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Farante G: Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 211: 250–259, 1990Google Scholar
  71. 71.
    Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J: Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst 86: 717–722, 1994Google Scholar
  72. 72.
    Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I: Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 74: 820–824, 1996Google Scholar
  73. 73.
    Smith TE, Lee D, Turner BC, Carter D, Haffty BG: True recurrence v.s. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int J Radiat Oncol Biol Phys 48: 1281–1289, 2000Google Scholar
  74. 74.
    Dewar JA, Arriagada R, Benhamou S, Benhamou E, Bretel JJ, Pellae-Cosset B, Marin JL, Petit JY, Contesso G, Sarrazin D: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer 76: 2260–2265, 1995Google Scholar
  75. 75.
    Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B: Contralateral breast cancer: metastasis or second primary cancer? Bull Cancer 83: 870–876, 1996Google Scholar
  76. 76.
    Abdalla I, Thisted RA, Heimann R: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. Cancer J 6: 266–272, 2000Google Scholar
  77. 77.
    Obedian E, Fischer DB, Haffty BG: Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18: 2406–2412, 2000Google Scholar
  78. 78.
    Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P: Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51: 679–690, 2001Google Scholar
  79. 79.
    Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR: Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52: 406–414, 2002Google Scholar
  80. 80.
    Deore SM, Sarin R, Dinshaw KA, Shrivastava SK: Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases. Int J Radiat Oncol Biol Phys 26: 601–606, 1993Google Scholar
  81. 81.
    Hill C: We should change the conduct of clinical trials in oncology. Bull Cancer 89: 823–825, 2002Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • J.M. Hannoun-Levi
    • 1
  • A. Courdi
    • 1
  • H. Marsiglia
    • 2
    • 3
  • M. Namer
    • 4
  • J.P. Gerard
    • 1
  1. 1.Department of Radiation OncologyCenter Antoine LacassagneNiceItaly
  2. 2.Department of Radiation OncologyInstitut Gustave RoussyVillejuifFrance
  3. 3.Brachytherapy Unit, Radiation Oncology DepartmentEuropean Institute of OncologyMilanItaly
  4. 4.Department of Medical OncologyCenter Antoine LacassagneNiceItaly

Personalised recommendations